Episode Description: Elections, Leprosy, and Alternative Proteins

In this episode, we delve into the recent presidential elections in Guatemala and Ecuador, exploring the different outcomes and approaches to governance. We also discuss the resurgence of leprosy in the southeastern United States, particularly in Florida, and the challenges associated with its diagnosis and treatment. Additionally, we explore Singapore's pioneering role in the alternative protein industry, examining the country's motivations, regulatory framework, and potential impact on the global market. Join us as we explore these diverse topics and their implications.

Guatemala's Presidential Election: Tackling Corruption and an Outsider Candidate

Guatemala recently held a presidential election, with Bernardo Arevalo emerging as the winner with 58% of the vote. Arevalo campaigned on promises to tackle corruption and was seen as an outsider candidate. We analyze the election results and the implications for Guatemala's future.

Ecuador's Election Runoff: Different Approaches to Governance

In Ecuador, no candidate received a majority in the recent election, leading to a runoff. We explore the two candidates who will compete in the runoff and their differing approaches to governance. One candidate looks backwards, while the other focuses on boosting the economy. We discuss the potential impact of these approaches on Ecuador's future.

The Resurgence of Leprosy in the United States

Leprosy, a bacterial infection, is making a comeback in the southeastern United States, particularly in Florida. While leprosy is curable with antibiotics, there is a risk of misdiagnosis due to its rarity. We examine the factors contributing to the resurgence of leprosy and the challenges associated with its diagnosis and treatment.

Singapore's Leadership in the Alternative Protein Industry

Singapore is at the forefront of the alternative protein industry, allowing the sale of cultivated meat and other alternative proteins. Driven by concerns over food security, the country aims to produce 30% of its food domestically by 2030. We delve into Singapore's efficient regulatory framework and approval process, which have attracted alternative protein companies to launch their products in the country first. We also discuss the challenges faced by the industry in scaling up production and reducing costs, while considering the potential global impact of Singapore's pioneering efforts.

Join us as we explore these diverse topics and their implications for politics, healthcare, and the future of food production.

Ecuador and Guatemala faced similar preoccupations with violence and corruption—one of Ecuador’s candidates was assassinated on the campaign trail—but their electoral outcomes were very different. What does that reveal about the region? Once rare in America, leprosy is on the rise again, particularly in Florida (8:04). And how Singapore leads the charge for “alternative proteins” (14:08). 

For full access to print, digital and audio editions of The Economist, try a free 30-day digital subscription by going to www.economist.com/intelligenceoffer

Hosted on Acast. See acast.com/privacy for more information.